CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 138 filers reported holding CATALYST PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 1.04 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $10,770,312 | -7.2% | 921,327 | +6.7% | 0.00% | 0.0% |
| Q2 2023 | $11,602,873 | -42.6% | 863,309 | -29.2% | 0.00% | -50.0% |
| Q1 2023 | $20,213,921 | -12.9% | 1,219,175 | -2.3% | 0.01% | -14.3% |
| Q4 2022 | $23,201,901 | +48.7% | 1,247,414 | +2.6% | 0.01% | +16.7% |
| Q3 2022 | $15,600,000 | +88.4% | 1,215,911 | +2.9% | 0.01% | +100.0% |
| Q2 2022 | $8,282,000 | +20.2% | 1,181,407 | +42.1% | 0.00% | +50.0% |
| Q1 2022 | $6,893,000 | +24.2% | 831,365 | +1.4% | 0.00% | 0.0% |
| Q4 2021 | $5,551,000 | +30.7% | 819,796 | +2.3% | 0.00% | +100.0% |
| Q3 2021 | $4,247,000 | -7.6% | 801,244 | +0.3% | 0.00% | -50.0% |
| Q2 2021 | $4,596,000 | +2.8% | 799,239 | -17.6% | 0.00% | 0.0% |
| Q1 2021 | $4,471,000 | +34.5% | 969,707 | -2.5% | 0.00% | +100.0% |
| Q4 2020 | $3,323,000 | +24.3% | 994,740 | +10.5% | 0.00% | 0.0% |
| Q3 2020 | $2,674,000 | -36.1% | 900,298 | -0.6% | 0.00% | -50.0% |
| Q2 2020 | $4,184,000 | +25.6% | 905,593 | +4.7% | 0.00% | 0.0% |
| Q1 2020 | $3,330,000 | +9.6% | 864,859 | +6.8% | 0.00% | 0.0% |
| Q4 2019 | $3,037,000 | +0.2% | 809,820 | +41.8% | 0.00% | 0.0% |
| Q3 2019 | $3,032,000 | +248.9% | 570,978 | +152.4% | 0.00% | +100.0% |
| Q2 2019 | $869,000 | -24.7% | 226,188 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $1,154,000 | +187.8% | 226,188 | +8.5% | 0.00% | – |
| Q4 2018 | $401,000 | -49.1% | 208,404 | 0.0% | 0.00% | -100.0% |
| Q3 2018 | $788,000 | +21.0% | 208,404 | 0.0% | 0.00% | – |
| Q2 2018 | $651,000 | +47.3% | 208,404 | +12.7% | 0.00% | – |
| Q1 2018 | $442,000 | -24.1% | 184,904 | +24.3% | 0.00% | – |
| Q4 2017 | $582,000 | +91.4% | 148,704 | +23.4% | 0.00% | – |
| Q3 2017 | $304,000 | -8.7% | 120,500 | 0.0% | 0.00% | – |
| Q2 2017 | $333,000 | +164.3% | 120,500 | +12.3% | 0.00% | – |
| Q1 2016 | $126,000 | -52.1% | 107,345 | 0.0% | 0.00% | – |
| Q4 2015 | $263,000 | -18.6% | 107,345 | 0.0% | 0.00% | – |
| Q3 2015 | $323,000 | -27.3% | 107,345 | 0.0% | 0.00% | -100.0% |
| Q2 2015 | $444,000 | – | 107,345 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANAKA CAPITAL MANAGEMENT INC | 208,189 | $1,726,000 | 3.48% |
| FRIESS ASSOCIATES LLC | 571,940 | $4,741,000 | 2.53% |
| GABLES CAPITAL MANAGEMENT INC. | 438,764 | $3,637,000 | 2.28% |
| Prairiewood Capital, LLC | 258,073 | $2,139,000 | 1.50% |
| Quantedge Capital Pte Ltd | 597,300 | $4,952,000 | 1.46% |
| ARMISTICE CAPITAL, LLC | 8,372,000 | $69,404,000 | 1.34% |
| SummerHaven Investment Management, LLC | 158,473 | $1,314,000 | 0.74% |
| Capital Impact Advisors, LLC | 99,322 | $823,000 | 0.60% |
| EAM Investors, LLC | 365,415 | $3,029,000 | 0.56% |
| GLOBEFLEX CAPITAL L P | 304,515 | $2,524,000 | 0.51% |